Caredx showcases digital solutions and pipeline in cellular transplant and therapy monitoring at the 2024 tandem meetings

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) —the transplant company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced that it will be showcasing the breadth of its specialized digital solutions and the latest advancements in its cellular therapy and transplant monitoring pipeline at the 2024 tandem meetings,.
CDNA Ratings Summary
CDNA Quant Ranking